A phase I/II study of low-dose of nedaplatin (CDGP) and 5-FU [fluorouracil] combined with radiation for the treatment of esophageal cancer
Phase of Trial: Phase I/II
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Fluorouracil (Primary) ; Nedaplatin (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Feb 2009 Official Title amended as reported by ClinicalTrials.gov.
- 19 Feb 2009 Patient numbers amended from 40 to 33 as reported by ClinicalTrials.gov.
- 19 Feb 2009 End date added from CliniclTrials.gov.